The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2017
Filed:
Jul. 25, 2013
Applicant:
University of Cincinnati, Cincinnati, OH (US);
Inventors:
Patrick Tso, Cincinnati, OH (US);
Xiaoming Li, Cincinnati, OH (US);
Assignee:
University of Cincinnati, Cincinnati, OH (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/28 (2006.01); A61K 38/16 (2006.01); A61P 3/10 (2006.01); A61P 7/12 (2006.01); C07K 1/00 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C09H 1/04 (2006.01); A61K 38/17 (2006.01); C07K 14/775 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1709 (2013.01); A61K 38/16 (2013.01); A61K 38/28 (2013.01); C07K 14/775 (2013.01);
Abstract
Methods for treating type one diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type one diabetes mellitus are disclosed, including combination therapies with insulin. The methods include administering an effective amount of apolipoprotein A-IV to the subject having type I diabetes. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type one diabetes mellitus.